These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8035015)

  • 1. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.
    Jenkins M; Landers D; Williams-Herman D; Wara D; Viscarello RR; Hammill HA; Kline MW; Shearer WT; Charlebois ED; Kohl S
    J Infect Dis; 1994 Aug; 170(2):308-12. PubMed ID: 8035015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study.
    Pugatch D; Sullivan JL; Pikora CA; Luzuriaga K
    J Infect Dis; 1997 Sep; 176(3):643-8. PubMed ID: 9291310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
    Jenkins M; Mills J; Kohl S
    Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting perinatal human immunodeficiency virus infection by antibody patterns.
    Moodley D; Bobat RA; Coutsoudis A; Coovadia HM
    Pediatr Infect Dis J; 1995 Oct; 14(10):850-2. PubMed ID: 8584310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity.
    Thomas AS; Moreau Y; Jiang W; Isaac JE; Ewing A; White LF; Kourtis AP; Sagar M
    Cell Rep Med; 2021 Oct; 2(10):100412. PubMed ID: 34755132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.
    Belo M; Yagello M; Girard M; Greenlee R; Deslandres A; Barré-Sinoussi F; Gluckman JC
    AIDS; 1991 Feb; 5(2):169-76. PubMed ID: 2031689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
    Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.
    Milligan C; Richardson BA; John-Stewart G; Nduati R; Overbaugh J
    Cell Host Microbe; 2015 Apr; 17(4):500-6. PubMed ID: 25856755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group.
    Parekh BS; Shaffer N; Coughlin R; Hung CH; Krasinski K; Abrams E; Bamji M; Thomas P; Hutson D; Schochetman G
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):907-12. PubMed ID: 8257638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.
    Omenda MM; Milligan C; Odem-Davis K; Nduati R; Richardson BA; Lynch J; John-Stewart G; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):163-6. PubMed ID: 23774880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical transmission of human immunodeficiency virus type 1. Prognostic value of IgA antibody to HIV-1 polypeptides during pregnancy.
    Re MC; Furlini G; Vignoli M; Ricchi E; Ramazzotti E; Bianchi S; Guerra B; Costigliola P; La Placa M
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):553-6. PubMed ID: 1424510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. For the Women and Infants Transmission Study.
    Pitt J; Henrard D; FitzGerald G; Mofenson L; Lew J; Hillyer G; Mendez H; Cooper E; Hanson C; Rich KC
    J Infect Dis; 2000 Oct; 182(4):1243-6. PubMed ID: 10979926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive measles immunity in a Nigerian tertiary health care facility: the influence of human immunodeficiency virus infection on measles antibody levels in mother-infant pairs at birth.
    Baba UA; Mustapha MG; Ashir GM; Rabasa AI; Ibrahim BA; Ibrahim HA
    West Afr J Med; 2012; 31(4):243-6. PubMed ID: 23468026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants.
    Palasanthiran P; Robertson P; Ziegler JB; Graham GG
    J Infect Dis; 1994 Dec; 170(6):1593-6. PubMed ID: 7996002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.